share_log

陽光能源:根據上市規則第13.51B(2)條作出的公告

SOLARGIGA: ANNOUNCEMENT MADE PURSUANT TO RULE 13.51B(2) OF THE LISTING RULES

Hong Kong Stock Exchange ·  Jun 14 19:43
Summary by Futu AI
陽光能源控股有限公司(「陽光能源」)於2024年6月14日發布公告,報告獨立非執行董事王永權博士於同年6月11日辭去德信中國獨立非執行董事一職,並於同日德信中國被香港特別行政區高等法院頒發清盤令。王博士於2019年1月11日至2024年6月11日間擔任該職位。德信中國主要從事物業開發、建築服務、物業投資及酒店運營,因未能償還350,000,000美元的優先票據本金及利息而面臨清盤。陽光能源董事會表示,此事件對陽光能源業務及營運無影響,王博士亦將繼續履行其於陽光能源的職責。公告依據上市規則第13.51B(2)條發布,以披露王博士的資料變更。
陽光能源控股有限公司(「陽光能源」)於2024年6月14日發布公告,報告獨立非執行董事王永權博士於同年6月11日辭去德信中國獨立非執行董事一職,並於同日德信中國被香港特別行政區高等法院頒發清盤令。王博士於2019年1月11日至2024年6月11日間擔任該職位。德信中國主要從事物業開發、建築服務、物業投資及酒店運營,因未能償還350,000,000美元的優先票據本金及利息而面臨清盤。陽光能源董事會表示,此事件對陽光能源業務及營運無影響,王博士亦將繼續履行其於陽光能源的職責。公告依據上市規則第13.51B(2)條發布,以披露王博士的資料變更。
Solargiga Holdings Limited ("Solargiga") announced on June 14, 2024 that Dr. Wang Wing Yuen, an independent non-executive director, had resigned as an independent non-executive director of Dexin China on June 11 of the same year and that Dexin China had been issued a winding-up order by the High Court of the Hong Kong Special Administrative Region on the same day. Dr. Wang had held the position from January 11, 2019 to June 11, 2024. Dexin China is mainly engaged in property development, construction services, property investment and hotel operation, and faced liquidation for failing to repay the principal and interest of USD 350,000,000 senior notes. The board of directors of Solargiga stated that this event had no impact on Solargiga's business and operations, and Dr. Wang would continue to fulfill his duties at Solargiga. The announcement was made in accordance with Rule 13.51B(2) of the Listing Rules in order to disclose the changes in Dr. Wang's information.
Solargiga Holdings Limited ("Solargiga") announced on June 14, 2024 that Dr. Wang Wing Yuen, an independent non-executive director, had resigned as an independent non-executive director of Dexin China on June 11 of the same year and that Dexin China had been issued a winding-up order by the High Court of the Hong Kong Special Administrative Region on the same day. Dr. Wang had held the position from January 11, 2019 to June 11, 2024. Dexin China is mainly engaged in property development, construction services, property investment and hotel operation, and faced liquidation for failing to repay the principal and interest of USD 350,000,000 senior notes. The board of directors of Solargiga stated that this event had no impact on Solargiga's business and operations, and Dr. Wang would continue to fulfill his duties at Solargiga. The announcement was made in accordance with Rule 13.51B(2) of the Listing Rules in order to disclose the changes in Dr. Wang's information.

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.